DAYVIGO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lemborexant.
Product ID | 62856-405_08ce5d4f-11e3-42c9-9e5a-801a3afca000 |
NDC | 62856-405 |
Product Type | Human Prescription Drug |
Proprietary Name | DAYVIGO |
Generic Name | Lemborexant |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-04-07 |
Marketing Category | NDA / NDA |
Application Number | NDA212028 |
Labeler Name | Eisai Inc. |
Substance Name | LEMBOREXANT |
Active Ingredient Strength | 5 mg/1 |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-04-07 |
NDC Exclude Flag | N |
Sample Package? | Y |
Marketing Category | NDA |
Application Number | NDA212028 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-04-07 |
Marketing Category | NDA |
Application Number | NDA212028 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-04-07 |
Marketing Category | NDA |
Application Number | NDA212028 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-04-07 |
Ingredient | Strength |
---|---|
LEMBOREXANT | 5 mg/1 |
SPL SET ID: | 7074cb65-77b3-45d2-8e8d-da8dc0f70bfd |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
62856-405 | DAYVIGO | lemborexant |
62856-410 | DAYVIGO | lemborexant |
62856-455 | DAYVIGO | lemborexant |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DAYVIGO 88655847 not registered Live/Pending |
Eisai R&D Management Co., Ltd. 2019-10-15 |
DAYVIGO 88058574 not registered Live/Pending |
Eisai R&D Management Co., Ltd. 2018-07-30 |